Treatment with DZNep depletes expression of PRC2 proteins EZH2, SUZ12, and associated 3MeK27H3 levels in cultured human MCL cells. Treatment with DZNep.

Slides:



Advertisements
Similar presentations
Glioma-derived soluble factor(s) enhance IL-10 signaling.
Advertisements

IL-1β stimulates CXCL5 and CXCL8 gene expression and protein secretion in A549 cells in a time- and dose-dependent manner. IL-1β stimulates CXCL5 and CXCL8.
Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against.
Interferon (IFN)-Induced Protein 35 (IFI35), a Type I Interferon-Dependent Transcript, Upregulates Inflammatory Signaling Pathways by Activating Toll-Like.
DHEA(S) and Allo induced the expression of the antiapoptotic Bcl-2 proteins in serum-deprived PC12 cells. DHEA(S) and Allo induced the expression of the.
A. D. B. C. - ΔNP63α - β-Actin IMEC - SUM MDA-MB IMEC
The BH3-mimetic GX synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of Bak by Patricia Pérez-Galán, Gaël.
Volume 11, Issue 6, Pages (June 2007)
Volume 11, Issue 6, Pages (June 2007)
HIF-1α is critically involved in hypoxia-induced CD137 upregulation.
NM-3 induces p21 levels and down-regulation of Cdk2 activity.
Supplementary Figure 1 A B C SW620 HT29 SW620
USP2a overexpression modifies the microRNA expression profile of prostate cells. USP2a overexpression modifies the microRNA expression profile of prostate.
Fig. 1. TSA at 165 nM induces maximal acetylation of histone H3 and near-maximal acetylation of histone H4.Immunoblot analysis of acetylated histones H3.
Knocking down Wnt3 increases the cells' response to trastuzumab and reduces cells' invasiveness. Knocking down Wnt3 increases the cells' response to trastuzumab.
Rosiglitazone induces Pdk4 expression in rat and human adipose tissue ex vivo and in 3T3–F442A adipocytes. Rosiglitazone induces Pdk4 expression in rat.
ONC201 activates the ISR. ONC201 activates the ISR. (A) Western blotting analysis for ATF4, CHOP, ATF3, and TRB3 on lysates from HCT116 cells cultured.
JAK3A572V mutation causes constitutive JAK3 activity and IL-2–independent proliferation of NKTCL cells. JAK3A572V mutation causes constitutive JAK3 activity.
Nrf2−/− mice had higher TGF-β1 transcription and FN expression.
MYC is a key determinant of cancer cell survival under p300- or CBP-depletion in CBP-KO or p300-KO cells, respectively. MYC is a key determinant of cancer.
LSD1, a histone demethylase, is required for the assembly of the Notch repressor complex. LSD1, a histone demethylase, is required for the assembly of.
d-PA, unlike n-PA, impairs EPC functions.
Accumulation of ubiquitinated MDM2 following PN treatment requires the PIKK ATM. A, Western blots of nuclear extract proteins from ZR-75-1 cells treated.
Aberrant regulation of HDAC2 and its association with malignant proliferation of human gastric cancer. Aberrant regulation of HDAC2 and its association.
VHL-, oxygen-, and proteasome-dependent regulation of AUF1 expression in RCC and 293T cells. VHL-, oxygen-, and proteasome-dependent regulation of AUF1.
B7-H1–induced reverse signals in myeloma cells.
Induction of CDCP1 is regulated by Ras in NSCLC cells.
BME treatment increases granzyme B expression in NK 3.3 cells.
TGF-β1 modulates extracellular matrix–mediated MT1-MMP expression.
ALDH1A3 is mainly responsible for the ALDH activity in two human cholangiocarcinoma lines. ALDH1A3 is mainly responsible for the ALDH activity in two human.
CNDT2.5 cells express mRNA for synaptophysin and neuron-specific enolase. CNDT2.5 cells express mRNA for synaptophysin and neuron-specific enolase. RT-PCR.
EGFR and cetuximab sensitivity of SCCUAT
CXCR4 expression levels of MDA-MB-231 cells at 48 hours posttransfection of CXCR4 siRNAs. CXCR4 expression levels of MDA-MB-231 cells at 48 hours posttransfection.
Western blot analysis of Wnt signaling genes.
A, one-step viral growth curves: RT treatment increased the virus yield in MV-CEA–treated U87 cells by up to 2 log as compared with MV-CEA infection only.
TDP1 and TOP1 protein levels correlate positively with TDP1 and TOP1 mRNA levels in colorectal cancer cell lines. TDP1 and TOP1 protein levels correlate.
Changes of gene expression induced by 1 mmol/L valproic acid in vitro.
A, RT-PCR expression of matriptase-1 and matriptase-2 in a variety of 24 human cell lines. A, RT-PCR expression of matriptase-1 and matriptase-2 in a variety.
Effect of SFN on the protein expression of Nrf2, HO-1, and NQO1 in JB6-shMock and JB6-shNrf2 cells. Effect of SFN on the protein expression of Nrf2, HO-1,
RT-PCR and Western blot analysis of cIAP2 mRNA and protein expression in ovarian cancer cells. RT-PCR and Western blot analysis of cIAP2 mRNA and protein.
The AKT–mTOR pathway controls PD-L1 protein expression.
Expression of S100A11 in bulk pancreatic tissues (pancreatic cancer, n = 22; IPMN, n = 18; nonneoplastic pancreas, n = 22). Expression of S100A11 in bulk.
Analysis of mRNA and protein levels of Loricrin, COMP, CXCL9, KRT19, and CYP 3A5 genes in OSFs compared with normal controls. Analysis of mRNA and protein.
DNA demethylation reactivates GSN expression in gastric cancer cells.
Nested RT-PCR of Mammaglobin and CK19 mRNA in plasma and circulating cells of controls (C) and patients (T) with breast cancer. Nested RT-PCR of Mammaglobin.
Bortezomib induces an NRF2 signature and NRF2 protein in tumor cells from leukemic MCL. Gene sets regulated by bortezomib (Supplementary Tables S3 and.
Platinum-based chemotherapy increased TXNIP expression, and overexpression of TXNIP enhanced the effectiveness of this therapy. Platinum-based chemotherapy.
NT157 treatment inhibits LNCaP xenograft growth and delays castration-resistant progression. NT157 treatment inhibits LNCaP xenograft growth and delays.
Reduced klotho expression in pancreatic cancer.
ODC protein expression in paired benign and cancer tissue obtained from patients with PCA. The protein expression was measured by immunoblot analysis in.
Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Expression.
Expression of HIF-1α and β-catenin in hypoxic HCC cell lines and HAL-treated xenografts. Expression of HIF-1α and β-catenin in hypoxic HCC cell lines and.
AS1411 alters subcellular distribution of PRMT5 in a time-dependent, dose-dependent, and nucleolin-dependent manner. AS1411 alters subcellular distribution.
Immunoblot analysis in PANC1 and MSTO-211H cells.
A, cellular uptake of AS1411 in MCF-7 and MCF-10A cells.
The effects of AZD1775 and olaparib on DNA damage response signaling.
BCR/ABL expression, tyrosine phosphorylation, and signaling in dasatinib- and imatinib-resistant cell lines and the ubiquitin inhibitor lactacystin modifies.
Levels and activity of c-myc are increased in a series of stably transfected DAOY and UW228 medulloblastoma cell lines. Levels and activity of c-myc are.
Induction of PARP cleavage (A) and activation of caspases (B) after treatment with a combination of TRAIL and cisplatin. Induction of PARP cleavage (A)
HOXA11-AS acts as a ceRNA for miR-1297.
Interaction of NHEJ and HR pathways in PCO cultures.
Effect of dexamethasone on PCDGF/GP88 mRNA and protein expressions and effect of PCDGF/GP88 on dexamethasone-induced cell death. Effect of dexamethasone.
Expression of chemokine receptors in A-498 cell line.
Blockade of cell cycle at G2-M phase in Bel-7402 cells treated with IG-105. Blockade of cell cycle at G2-M phase in Bel-7402 cells treated with IG-105.
IL-1β expression is increased in MM cell lines by the co-culture with platelets in vitro. IL-1β expression is increased in MM cell lines by the co-culture.
Depletion of murine Dnmt proteins after 5-Aza-CdR treatment.
Effect of SFN on the total activity and protein expression of HDACs in JB6 P+ cells. Effect of SFN on the total activity and protein expression of HDACs.
Inhibition of HDACs disrupts DNMT1 association with Hsp90.
CREB1 binds at the proximal region of the TGFB2 promoter and induces its transcriptional activation. CREB1 binds at the proximal region of the TGFB2 promoter.
Determination of Per2 (left), MTNR1A (middle), and ERβ (right) protein expression levels in mammary tissues of rats sacrificed at ZT12. Determination of.
Presentation transcript:

Treatment with DZNep depletes expression of PRC2 proteins EZH2, SUZ12, and associated 3MeK27H3 levels in cultured human MCL cells. Treatment with DZNep depletes expression of PRC2 proteins EZH2, SUZ12, and associated 3MeK27H3 levels in cultured human MCL cells. A, immunoblot analyses of EZH2, SUZ12, EED, BMI1, and β-actin in JeKo-1 cells following 24 hours treatment with DZNep. B, immunoblot analyses of EZH2, SUZ12, EED, BMI1, and β-actin in primary MCL cells after treatment with DZNep for 24 hours. C, quantitative RT-PCR for EZH2 and SUZ12 in MO2058 and JeKo1 treated with DZNep for 16 hours. The relative quantity (RQ) of each mRNA was normalized against glyceraldehyde-3-phosphate dehydrogenase expression. D, immunoblot analyses of 3Me K27H3, 3MeK4H3, 3MeK79H3, 3MeK9H3, AcK16H4, AcK27H3, AcK56H3, and histone H3 on acid-extracted histones from JeKo-1 cells treated with DZNep for 24 hours. E, JeKo-1 cells were treated with DZNep for 4 hours. Following this, EZH2 was immunoprecipitated and immunoblot analyses were conducted for DNMT1, SUZ12, EED, and EZH2 on the immunoprecipitates. The numbers beneath the blots represent densitometric evaluation of band intensity of the proteins bound to EZH2 in the immunoprecipitates. Warren Fiskus et al. Clin Cancer Res 2012;18:6227-6238 ©2012 by American Association for Cancer Research